I alle de placebo kontrollerede undersøgelser var den hyppigste rapporterede uønskede hændelsen med Kineret en reaktion ved injektionsstedet, som var mild til moderat hos hovedparten af patienterne.
In all placebo-controlled studies, the most frequently reported adverse event with Kineret was injection site reaction (ISRs), which was mild to moderate in the majority of patients.